# Support for Patients and Communities Reauthorization Act

This bill extends and increases federal funding for programs that help people struggling with opioid addiction and related health issues. Think of it as Congress renewing its commitment to fighting the opioid crisis by keeping existing programs running and giving them more money to do their work.

The bill focuses on three main areas. First, it pumps more money into public health programs that prevent overdoses, treat addiction, and support recovery. This includes funding for training first responders to use overdose-reversal drugs like Narcan, helping pregnant women get residential treatment for addiction, and supporting people in recovery through community programs. It also increases money for training mental health and addiction treatment workers, and creates a loan repayment program to help attract people to work in addiction treatment—a field that currently has serious staffing shortages. Additionally, the bill funds programs to detect dangerous synthetic opioids like fentanyl in communities and to help people who've experienced trauma, which is often connected to substance use.

Second, the bill makes some technical changes to how controlled substances are handled. It allows pharmacies to deliver certain medications to doctors' offices more easily, reviews how buprenorphine-naloxone (a medication that treats opioid addiction) is classified, and addresses the growing problem of illicit xylazine, a dangerous animal tranquilizer increasingly mixed into street drugs. Third, it requires state Medicaid programs to continue covering medication-assisted treatment for opioid addiction and expands data collection on how these treatments are working.

Overall, the bill extends these programs through 2028 and increases annual funding across the board—for example, first responder training funding jumps from $36 million to $56 million per year, and funding for community recovery programs triples from $5 million to $16 million annually. This affects anyone struggling with addiction, their families, healthcare providers, first responders, and communities dealing with the opioid crisis.

Support for Patients and Communities Reauthorization Act

Guthrie, Brett

Support for Patients and Communities Reauthorization Act This bill reauthorizes through FY2028 and modifies various grants, programs, and activities that address substance use and misuse. This includes reauthorizing (1) data collection, education, and surveillance activities; (2) grants and other support for substance use disorder prevention, treatment, and recovery; (3) student loan repayment and other programs for the substance use disorder workforce; and (4) programs for addressing trauma, particularly for children, youth, and their families. Generally, the modifications expand programs. Additionally, the bill modifies provisions related to the scheduling of controlled substances, including by incorporating illicit xylazine (a compound used in veterinary medicine as a nonopioid tranquilizer) into schedule III of the Controlled Substances Act. Further, the bill makes permanent a requirement that Medicaid programs cover medication-assisted treatment for individuals with substance use disorders.